Form 4: Schwab Director Sells $4.5M in Stock Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


A director at The Charles Schwab Corporation sold over 42,000 shares of common stock for approximately $4.5 million through a pre-arranged trading plan.

Summary

  • Carolyn Schwab-Pomerantz, a Director of The Charles Schwab Corporation (SCHW), reported the sale of 42,865 shares of common stock.
  • The sales were executed on January 22, 2026, through multiple trades at weighted average prices ranging from $105.0158 to $105.2473 per share.
  • The total value of the shares sold amounts to approximately $4,510,012.09.
  • These transactions were made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
  • Following these transactions, Carolyn Schwab-Pomerantz's indirect beneficial ownership through a Trust is 1,396,458.6599 shares, through a Spouse as Trustee is 436,149 shares, and through an LLC is 2,798 shares. Direct beneficial ownership is 9,624 shares.

Sentiment

Score: 5

Explanation: The filing reports a pre-planned insider stock sale, which is a routine event and does not directly reflect on the company's operational performance or future prospects. It is a neutral event from an investment perspective.

Positives

  • The sales were executed at a relatively strong price point, averaging over $105 per share.
  • The use of a Rule 10b5-1 plan indicates that these sales were pre-scheduled and not based on material non-public information, which enhances transparency and reduces concerns about opportunistic insider trading.

Negatives

  • The filing reports a reduction in the beneficial ownership of common stock by a director, which can sometimes be perceived negatively by the market, even if pre-planned.

Future Outlook

This Form 4 filing reports past (or future-dated, as per the filing) insider transactions and does not contain specific forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Insider stock sales, particularly those executed under Rule 10b5-1 plans, are a common occurrence across all industries for executives and directors to manage personal finances, diversify portfolios, or for liquidity. The financial services industry, where The Charles Schwab Corporation operates, frequently sees such filings due to the significant equity compensation structures for its leadership.

Comparison to Industry Standards

  • This Form 4 filing is standard for reporting insider stock sales in the U.S. market.
  • The transaction size, approximately $4.5 million, is significant but not unusual for a director of a large, established financial institution like The Charles Schwab Corporation.
  • The use of a Rule 10b5-1 plan aligns with best practices for corporate governance, demonstrating a pre-planned approach to stock sales rather than reactive trading.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Authorization for SEC FilingsCarolyn Schwab-Pomerantz executed a Power of Attorney appointing P. Blake Allen, Kristopher R. Tate, and Lucy Yiheng Liu to prepare, execute, and file Forms 3, 4, and 5 on her behalf with the SEC.December 11, 2025Streamlines compliance with Section 16 of the Exchange Act for the reporting person, ensuring timely and accurate filings.

Related Party Transactions

  • Sale of common stock by Carolyn Schwab-Pomerantz, a director of The Charles Schwab Corporation.
  • Indirect beneficial ownership through a Trust, Spouse as Trustee, and an LLC, which are related parties to the director.

Stakeholder Impact

  • Shareholders: May note the director's sale, but the pre-planned nature under Rule 10b5-1 typically mitigates concerns about insider sentiment.
  • Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction report.

Next Steps

  • The reporting person will continue to file Form 4s as required for any future changes in beneficial ownership of The Charles Schwab Corporation securities.

Key Dates

DateDescription
December 11, 2025Power of Attorney executed by Carolyn Schwab-Pomerantz.
January 22, 2026Date of reported common stock transactions.
January 26, 2026Date the Form 4 was signed by the attorney-in-fact.

Recommendation

hold

The filing details a pre-planned sale of common stock by a director under a Rule 10b5-1 plan. This is a routine insider transaction for diversification or liquidity purposes and does not provide new information that would fundamentally alter the investment thesis for The Charles Schwab Corporation. Therefore, a 'hold' recommendation is maintained, pending further operational or strategic updates.

Keywords

Charles Schwab, SCHW, Insider Trading, Form 4, Stock Sale, Director, 10b5-1 Plan, Equity Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.